Physician profile
Danny Ly
NPI 1366064503
$1,322.92
in general payments reported to CMS, 2019-2025
8 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.88 · 2023: $509 · 2024: $469 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $565.36 | 2022-2025 | Total30, Precision7, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $248.96 | 2022-2024 | Acuvue |
| Abbvie INC. | $131.97 | 2023 | |
| Apellis Pharmaceuticals, INC. | $121.81 | 2023 | Syfovre |
| Biotissue Holdings INC. | $120.57 | 2024 | |
| Bausch & Lomb Americas INC. | $91.98 | 2024 | Alden Scleral Zenlens, Infuse |
| Coopervision INC. | $29.29 | 2023-2024 | Paragon Crt |
| Sight Sciences, INC. | $12.98 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.